Skip to content
Stop using now Drug recall · FDA · Published October 6, 2014

Hospira Recalls Propofol Vials Due to Temperature Abuse

Hospira Inc. recalls Propofol Injectable Emulsion vials due to uncontrolled temperature excursions during transit. Check lot numbers and expiration dates.

🇺🇸 FDA recall #D-0389-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling Propofol Injectable Emulsion, 1%, 200 mg/20 mL single patient infusion vials because the products experienced uncontrolled temperature excursions during transit. This recall affects one shipment of Lot #33-750-DJ with an expiration date of September 1, 2015. The affected product was distributed to The Harvard Drug Group in Livonia, MI. Read more at govinfonow.com/recall/45685-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20.

Source Summary by GovInfoNow · govinfonow.com/recall/45685-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0389-2015

Cite this page

“Hospira Recalls Propofol Vials Due to Temperature Abuse.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45685-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20. Based on FDA recall #D-0389-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0389-2015%22&limit=1).

The FDA announced on 2014-10-06 that Hospira Inc. is recalling Propofol Injectable Emulsion due to temperature abuse during transit, according to the FDA. The recall affects a single shipment of 2,500 vials distributed nationwide for Vancomycin lots but limited to The Harvard Drug Group in Livonia, MI for the affected lots.

How to tell if you have it

  • Brand: Hospira
  • Product: Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials
  • NDC: 0409-4699-30
  • Lot #: 33-750-DJ
  • Expiration Date: Exp 1SEP2015
  • Quantity: 2,500 vials

The hazard

The products experienced uncontrolled temperature excursions during transit, according to the FDA. This hazard classifies the recall as Class I.

Context

GovInfoNow's records show Hospira Inc. has had 108 other recalls since 2012-04-05. In 2017-04-21, Hospira recalled Infant Dextrose Injection due to hair particulates in syringes. On 2016-11-01, the company recalled Fentanyl Injection because of broken ampule tips risking infection. Other recent recalls of similar products include TerSera's Zoladex Implants (2026-08-31), McKesson's UDENYCA Injection (2026-01-16), and McKesson's Gemcitabine Injection (2026-06-10).

How to tell if you have this one

Look for Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), packaged as 20 mL single patient infusion vials. Check for NDC 0409-4699-30 and Lot #33-750-DJ with an expiration date of 1SEP2015. The product was distributed to The Harvard Drug Group in Livonia, MI.

  • Brand
    Hospira
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Status
    Terminated
  • Distribution
    Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribution was Nationwide for the Vancomycin 1 g product.
Recall numberProduct, codes & lotsQuantityClassNDC
D-0387-2015Vancomycin Hydrochloride for Injection, USP, 500 mg Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4332-01.; One shipment of Lot #: 34-366-8E02; Exp 1OCT2015 to The Harvard Drug Group, Livonia, MI200 vialsClass II0409-6531-12, 0409-6531-02, 0409-6533-11, 0409-6533-01, 0409-6533-21, 0409-4332-11, 0409-4332-01, 0409-3515-11, 0409-3515-01
D-0388-2015Ketorolac Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Single-dose Fliptop Vial, packaged in 25 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-3796-01.; One shipment of Lot #: 34-540-DK; Exp 1OCT2015 to The Harvard Drug Group, Livonia, MI100 vialsClass II0409-3793-19, 0409-3793-01, 0409-3793-25, 0409-3795-19, 0409-3795-01, 0409-3795-25, 0409-3796-19, 0409-3796-01, 0409-3796-25
D-0389-2015Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.; One shipment of Lot #: 33-750-DJ; Exp 1SEP2015 to The Harvard Drug Group, Livonia, MI2,500 vialsClass I0409-4699-50, 0409-4699-30, 0409-4699-53, 0409-4699-33, 0409-4699-54, 0409-4699-24, 0409-6010-02, 0409-6010-25
D-0390-2015Vancomycin Hydrochloride for Injection, USP, 1 g Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-6533-01.; Lot #: 35-315-DD; Exp 1NOV201590,600 vialsClass II0409-6531-12, 0409-6531-02, 0409-6533-11, 0409-6533-01, 0409-6533-21, 0409-4332-11, 0409-4332-01, 0409-3515-11, 0409-3515-01
Based on the official FDA remedy

What to do — step by step

  1. Check Inventory

    Identify any Propofol Injectable Emulsion vials matching NDC 0409-4699-30 and Lot #33-750-DJ with an expiration date of 1SEP2015.

  2. Stop Distribution

    Ensure the recalled product remains within the control of The Harvard Drug Group and is not further distributed to other locations.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Oct 6, 201412. FDA classified it Class I: Feb 13, 201523. Published in FDA’s Enforcement Report: Feb 25, 201534. FDA terminated the recall: Dec 15, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled item?

The National Drug Code (NDC) is 0409-4699-30.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0389-2015 (October 6, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0389-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA